Structured evidence table for Vitamin C Skin Health Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Vitamin C Skin Health Randomized Trial | p p 1 The THD‐AA serum reduced ROS formation by 88% after 30 min, 87% after 60 min, and 82% after 120 min. | 4 | Maloney McKenzie E. (2026) | Hydroquinone‐Free, Tetrahexyldecyl Ascorbate Antioxidant Serum for Hyperpigmented and Photodamaged Skin to Achieve Skin Health |
| Vitamin C Skin Health Randomized Trial | At week 12 the following statistics were found in the THD‐AA serum group: The results from the subjective self‐assessment conducted at week 12 were as follows: There were no significant changes from baseline for any tolerability parameter (burning, itching, or stinging). | 4 | Maloney McKenzie E. (2026) | Hydroquinone‐Free, Tetrahexyldecyl Ascorbate Antioxidant Serum for Hyperpigmented and Photodamaged Skin to Achieve Skin Health |
| Vitamin C Skin Health Randomized Trial | This represents a 22%–42% enhancement in antioxidant activity compared to other derivatives, likely a result of its superior skin penetration [,,]. | 4 | Maloney McKenzie E. (2026) | Hydroquinone‐Free, Tetrahexyldecyl Ascorbate Antioxidant Serum for Hyperpigmented and Photodamaged Skin to Achieve Skin Health |
| Vitamin C Skin Health Randomized Trial | AA DEJ FDA HEV OTC ROS THD THD‐AA Serum 1 2 3 2 4 5 Photodamage accelerates the natural skin aging process, upregulating collagen degradation, downregulating collagen synthesis, and accelerating the production of free radicals. | 4 | Maloney McKenzie E. (2026) | Hydroquinone‐Free, Tetrahexyldecyl Ascorbate Antioxidant Serum for Hyperpigmented and Photodamaged Skin to Achieve Skin Health |
Source documents